Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) is one of the oldest diseases known to humanity, with evidence of its existence dating back thousands of years. Despite the availability of effective treatments, TB causes morbidity and mortality globally, with special reference to low- and middle-income countries (LMICs). In recent years, advancements in molecular diagnostics have transformed the landscape of TB detection. Nucleic acid amplification tests (NAAT) techniques such as polymerase chain reaction (PCR) have rapidly emerged and are well developed, offering timely and accurate identification of MTB. This chapter aims to provide a comprehensive overview of the traditional and modern diagnostic methods in clinical laboratories for MTB detection, exploring the challenges faced in TB diagnosis and the implications for public health. By understanding the intricacies of TB diagnostics, we can better address the ongoing global challenge posed by this ancient yet persistent disease, ultimately working toward a TB-free world.
Differential diagnosis of tuberculosis (TB) and non-tuberculous mycobacteria (NTM) is extremely challenging, especially in a high TB burden setting like India. A definitive diagnosis of NTM, along with additional speciation, is warranted to improve NTM management. Beyond the diagnosis of NTM and its speciation, clinical correlation is vital for differentiating NTM colonisation or contamination from disease. In this cross-sectional, retrospective analysis, both pulmonary and extrapulmonary samples from 1121 presumptive NTM patients from Tuberculosis Units across the country and from other private hospitals were included. Composite diagnosis were performed using X-rays, nucleic acid amplification tests, smear microscopy, and mycobacterial growth indicator tube cultures, with speciation of NTM isolates confirmed by line probe assay. Of the 1121 presumptive NTM patients, 66.0% were smear-negative, 44.7% had X-ray changes, and 98.0% were M. tuberculosis-negative according to the nucleic acid amplification test. Cultures identified 310 patients as NTM-positive, including 22 extrapulmonary cases. Speciation was performed for 135 NTM-positive isolates, where M. abscessus was identified as the predominant species in 30.4%, followed by M. kansasii in 25.1%. Our study demonstrated that although the composite diagnosis of NTM holds promise for identifying pulmonary and extrapulmonary NTM, culture (mean confirmation rate of 30–40% over 5 years) remains the gold standard, with NTM speciation by line probe assay completing the diagnosis.